HomeREGULATORY

REGULATORY

Artificial intelligence

AI Act, the beginning of a new era

GMP

Ensuring excellence in aseptic processing: key highlights from EU GMP Annex 1

EVENTS

eQMS in Pharma: the Effect of Digitalization

Guidelines

General principles, Pharmaceutical Quality System and personnel requirements in Annex 1

ESG

New 2024 sustainability rules

Guidelines

AI and drugs regulation, the UK example

REGULATORY

X-Rays for sterilization

Legislation

Deal on new rules for more sustainable packaging in the EU

ESG

European packaging regulation: ‘single market at risk’ according to associations

Legislation

Clinical Trials Regulation and the Italian alignment

Legislation

62° AFI Symposium – Antonella Mamoli’s interview

Legislation

62° AFI Symposium – Paola Minghetti’s interview

Pharmacovigilance

62° AFI Symposium – Andrea Oliva’s interview

API & Excipients

62°AFI Symposium – Piero Iamartino’s interview

Legislation

62° AFI Symposium – Antonio Conto’s interview

Legislation

When the solution risks turning into a new problem

Legislation

EU pharmaceutical legislation

Legislation

CE certifications of medical devices: bottleneck alert

Legislation

Advertising of medical devices, what changes with the new European regulation

Clinical research

Farmindustria concerns about implementing decrees delay

12Page 1 of 2
spot_img
spot_img
spot_img
spot_img
spot_img